The global laboratory centrifuges market is expected to grow from USD 1.58 billion in 2025 to USD 1.86 billion by 2030, registering a compound annual growth rate (CAGR) of 2.8% during the forecast period.
Laboratory centrifuges are fundamental instruments used across chemistry, biology, biochemistry, molecular biology, clinical diagnostics, and pharmaceutical research. They enable the separation and purification of cells, subcellular organelles, viruses, proteins, nucleic acids, and other biological components, making them indispensable for both routine laboratory operations and advanced biomedical research.
Although the market is relatively mature compared with other life science instrumentation segments, continued growth is being supported by increasing research and development investments, technological improvements in centrifuge design, rising infectious disease testing volumes, and expanding applications in cell-based and molecular research workflows.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197749088
Why Laboratory Centrifuges Remain Essential
Centrifugation is one of the most widely used sample preparation techniques in laboratory science. By applying centrifugal force, these instruments separate components based on density, size, and sedimentation characteristics.
Laboratory centrifuges are used in applications such as:
- Blood and plasma separation
- Cell harvesting and washing
- DNA and RNA extraction
- Protein purification
- Virus concentration
- Subcellular fractionation
- Clinical sample preparation
- Biopharmaceutical process development
Their versatility makes them critical tools across academic institutions, hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology firms, and contract research organizations (CROs).
Key Factors Driving Market Growth
Increasing R&D Investments and Research Grants
Governments, academic institutions, and private-sector organizations continue to increase funding for life sciences, genomics, proteomics, immunology, and drug discovery research.
Many of these research activities require extensive sample preparation and separation steps, driving sustained demand for:
- Benchtop centrifuges
- High-speed centrifuges
- Refrigerated centrifuges
- Ultracentrifuges
- Multi-purpose centrifuge systems
As research programs become more sophisticated, laboratories increasingly seek centrifuges that offer higher throughput, improved temperature control, and enhanced automation capabilities.
Technological Advancements and Innovative Rotor Designs
Manufacturers are continuously improving centrifuge performance through innovations such as:
- Advanced rotor materials
- Aerosol-tight safety rotors
- Automatic rotor recognition
- Energy-efficient drive systems
- Touchscreen interfaces
- Programmable run protocols
- Remote monitoring capabilities
Modern rotor designs improve sample safety, operational efficiency, and ease of use, while also reducing maintenance requirements and extending instrument lifespan.
Request for Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=197749088
Growing Infectious Disease Testing and Cell-Based Research
The increasing prevalence of infectious diseases and the expansion of molecular diagnostics, vaccine research, immunology studies, and cell-based assays have increased the volume of biological samples requiring centrifugation.
Centrifuges play a crucial role in:
- PCR sample preparation
- Viral RNA extraction
- Cell culture processing
- Immunological assays
- Clinical microbiology workflows
- Vaccine development and quality control
The continued expansion of cell therapy, regenerative medicine, and personalized medicine research is also contributing to sustained demand for advanced centrifugation technologies.
Expanding Application Areas
Laboratory centrifuges are increasingly being used beyond traditional research settings in areas such as:
- Biobanking
- Forensic science
- Environmental testing
- Food and beverage analysis
- Veterinary diagnostics
- Industrial biotechnology
- Point-of-care laboratory workflows
This broadening application base is helping maintain steady market growth despite the maturity of the core centrifuge industry.
Asia Pacific Emerges as the Fastest-Growing Region
While North America and Europe remain major established markets, Asia Pacific is projected to be the fastest-growing regional market during the forecast period.
Key growth drivers in the region include:
- Rapid expansion of pharmaceutical and biotechnology industries
- Increasing government investment in life science research
- Growth of academic and clinical research infrastructure
- Rising demand for diagnostic testing services
- Expanding biomanufacturing and vaccine production capabilities
Emerging economies such as China and India are investing heavily in biotechnology innovation, genomic research, and healthcare infrastructure, creating substantial opportunities for laboratory equipment manufacturers.
Competitive Landscape
The laboratory centrifuges market is highly competitive but relatively consolidated, with a limited number of well-established players holding significant global market share.
Major companies operating in the market include:
- Thermo Fisher Scientific, Inc. (US)
- Danaher Corporation (US)
- Eppendorf AG (Germany)
- KUBOTA Corporation (Japan)
- Sigma Laborzentrifugen GmbH (Germany)
- NuAire (US)
- Sartorius AG (Germany)
- Andreas Hettich GmbH & Co. KG (Germany)
- HERMLE Labortechnik GmbH (Germany)
- Cardinal Health (US)
- Agilent Technologies (US)
- Centurion Scientific (UK)
- QIAGEN N.V. (Netherlands)
- Bio-Rad Laboratories, Inc. (US)
Market leaders maintain their positions through:
- Strong brand credibility
- Broad product portfolios
- Advanced engineering capabilities
- Global distribution and service networks
- Regulatory expertise
- Long-term customer relationships
- Integration with broader laboratory workflows
Thermo Fisher Scientific: Global Market Leader
Thermo Fisher Scientific is widely recognized as the leading player in the global laboratory centrifuges market.
Key competitive strengths include:
- Extensive centrifuge product portfolio
- Strong global brand recognition
- Significant investment in research and development
- Comprehensive sales and service infrastructure
- Integration with broader laboratory and life science workflows
The company offers centrifuges across multiple categories, including:
- Microcentrifuges
- General-purpose centrifuges
- Refrigerated centrifuges
- High-speed centrifuges
- Floor-standing centrifuges
- Ultracentrifuge systems
Thermo Fisher’s strong emphasis on continuous product development and global customer support has helped it maintain leadership across academic, clinical, pharmaceutical, and industrial laboratory markets.
The company’s presence in more than 600 locations worldwide provides a significant advantage in terms of customer service, technical support, and distribution reach.
Danaher: Strength Through Beckman Coulter
Danaher Corporation is another major force in the laboratory centrifuges market, primarily through its Beckman Coulter life sciences and diagnostics businesses.
Strategic advantages include:
- Broad clinical diagnostics portfolio
- Strong expertise in automation and workflow integration
- Extensive manufacturing and distribution infrastructure
- Proven acquisition and integration capabilities through the Danaher Business System (DBS)
One notable product innovation is the Avanti JXN-30 centrifuge, which supports high-performance research and bioprocessing applications.
Danaher’s acquisition-driven growth strategy has allowed it to strengthen its position across clinical diagnostics, life sciences research, and biopharmaceutical processing, creating valuable synergies between centrifugation technologies and other laboratory automation platforms.
With 242 manufacturing and distribution facilities worldwide, the company has a substantial global operational footprint.
Eppendorf: Innovation-Focused Market Leader
Eppendorf AG has built a strong reputation for precision engineering and product innovation in laboratory centrifugation.
Recent product launches include:
- Multipurpose Centrifuge 5910 Ri
- Refrigerated 24-place centrifuge 5425 R
- Refrigerated 24-place centrifuge 5425
These products strengthen Eppendorf’s position in:
- Molecular biology laboratories
- Cell culture facilities
- Clinical research environments
- Academic research institutions
- Biopharmaceutical development laboratories
The company’s acquisition of Koki Holdings Co., Ltd. (Japan) has further expanded its centrifuge portfolio, adding capabilities in high-speed, ultra-speed, and specialized centrifugation systems.
Eppendorf’s global presence across Europe, North America, South America, Asia Pacific, and Africa, combined with subsidiaries in more than 28 countries, gives it strong international market coverage.
Market Ranking and Competitive Positioning
The laboratory centrifuges market is considered fairly consolidated, with five to six major players collectively accounting for approximately 50–60% of global market share.
Approximate competitive positioning
1. Thermo Fisher Scientific
- Broadest product portfolio
- Strongest global distribution network
- Highest R&D investment levels
- Extensive service and support capabilities
2. Danaher Corporation
- Strong clinical diagnostics integration
- Advanced automation expertise
- Beckman Coulter brand strength
- Large-scale global operations
3. Eppendorf AG
- Strong reputation in molecular biology and research laboratories
- Focus on ergonomic and innovative centrifuge design
- Expanding high-speed and ultra-speed centrifuge capabilities
Other important contributors such as KUBOTA, Sigma Laborzentrifugen, Hettich, HERMLE, Sartorius, Agilent, and Bio-Rad maintain strong positions in specific application segments and regional markets.
Emerging Technology Trends
Smart and Connected Centrifuges
Manufacturers are increasingly incorporating digital connectivity features, including:
- Wi-Fi and Ethernet connectivity
- Remote diagnostics
- Predictive maintenance alerts
- Cloud-based performance monitoring
- Electronic audit trails for regulated environments
These capabilities support laboratory digitalization and compliance with modern quality management systems.
Energy Efficiency and Sustainability
Laboratories are placing greater emphasis on energy-efficient equipment that reduces operating costs and supports sustainability goals.
Newer centrifuge systems are being designed with:
- Lower power consumption
- Improved refrigeration efficiency
- Reduced heat generation
- Longer component lifespans
- More sustainable manufacturing materials
Enhanced Biosafety Features
Growing concern about infectious and hazardous biological samples is driving demand for centrifuges with:
- Aerosol-tight rotors
- Automatic lid-locking mechanisms
- Imbalance detection systems
- Sealed bucket designs
- Improved decontamination compatibility
These features are becoming increasingly important in clinical diagnostics, microbiology, and high-containment research laboratories.
Challenges Facing the Market
Despite steady growth, the laboratory centrifuges market faces several challenges.
Market Maturity
Centrifuges are established laboratory instruments with relatively long replacement cycles, limiting opportunities for rapid market expansion compared with newer life science technologies.
Price Competition
Intense competition among established manufacturers and lower-cost regional suppliers can place pressure on pricing and profit margins, particularly in standard benchtop centrifuge segments.
Maintenance and Calibration Requirements
High-performance centrifuges require regular:
- Calibration
- Rotor inspection
- Preventive maintenance
- Compliance verification
These ongoing operational requirements can increase total cost of ownership for laboratory operators.
Budget Constraints in Academic Institutions
Many universities and public research laboratories face constrained capital equipment budgets, which can delay centrifuge replacement and upgrade decisions.
Future Outlook Through 2030
Although the projected 2.8% CAGR indicates moderate growth, the laboratory centrifuges market is expected to remain stable and strategically important within the broader laboratory equipment industry.
Growth will be supported by:
- Continued expansion of biopharmaceutical R&D
- Rising adoption of cell and gene therapy research
- Increasing molecular diagnostic testing volumes
- Growth of biobanking and precision medicine initiatives
- Modernization of laboratory infrastructure in emerging markets
- Replacement demand for aging centrifuge equipment
The market’s evolution will likely focus less on dramatic volume growth and more on higher-value innovations involving automation, connectivity, biosafety, energy efficiency, and workflow integration.
Conclusion
Laboratory centrifuges remain one of the most essential and widely used instruments in research, clinical diagnostics, molecular biology, and biopharmaceutical development. Their critical role in sample preparation, cell separation, nucleic acid purification, and protein isolation ensures continued demand across a broad range of scientific and healthcare applications.
The market is being driven by increasing R&D investment, technological improvements in rotor and refrigeration systems, expanding infectious disease testing, and growing cell-based research activities, while Asia Pacific emerges as the fastest-growing regional opportunity.
Leading companies such as Thermo Fisher Scientific, Danaher, and Eppendorf continue to strengthen their positions through product innovation, global expansion, workflow integration, and strategic acquisitions. As laboratories worldwide pursue greater efficiency, biosafety, automation, and digital connectivity, the laboratory centrifuges market is expected to maintain steady long-term growth and remain a foundational component of modern laboratory infrastructure through 2030 and beyond.
For more information, Inquire Now!